世界の開放隅角緑内障治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Open-Angle Glaucoma Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5909
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、100ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、開放隅角緑内障治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（プロスタグランジン類似体（PGA）、PGA組み合わせ、その他）、用途別市場規模（病院、クリニック、研究所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・開放隅角緑内障治療薬の市場動向
・企業の競争状況、市場シェア
・開放隅角緑内障治療薬の種類別市場規模と予測2016-2027（プロスタグランジン類似体（PGA）、PGA組み合わせ、その他）
・開放隅角緑内障治療薬の用途別市場規模と予測2016-2027（病院、クリニック、研究所、その他）
・開放隅角緑内障治療薬の北米市場規模2016-2027（アメリカ、カナダ）
・開放隅角緑内障治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・開放隅角緑内障治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・開放隅角緑内障治療薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・開放隅角緑内障治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Aerie Pharmaceuticals Inc.、Allergan Plc、Bausch Health Companies, Inc.、Novartis AG、Pfizer Inc.）
・結論

Glaucoma is a group of eye diseases which result in damage to the optic nerve and cause vision loss.
The increasing demand for combination drugs will be one of the primary drivers of the open-angle glaucoma therapeutics market. Combination drugs have minimal adverse effects and help in overcoming the limitations of monotherapy. Combination drugs also help in improving tolerability by allowing the use of the two compounds below their dose thresholds.

Market Analysis and Insights: Global Open-Angle Glaucoma Therapeutics Market
The global Open-Angle Glaucoma Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Open-Angle Glaucoma Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Open-Angle Glaucoma Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Open-Angle Glaucoma Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Open-Angle Glaucoma Therapeutics market.

Global Open-Angle Glaucoma Therapeutics Scope and Market Size
Open-Angle Glaucoma Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Open-Angle Glaucoma Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Prostaglandin Analogs (PGAs)
Combination of PGAs
Other

Segment by Application
Hospital
Clinic
Research Institute
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Aerie Pharmaceuticals Inc.
Allergan Plc
Bausch Health Companies, Inc.
Novartis AG
Pfizer Inc.

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Open-Angle Glaucoma Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Prostaglandin Analogs (PGAs)
1.2.3 Combination of PGAs
1.2.4 Other
1.3 Market by Application
1.3.1 Global Open-Angle Glaucoma Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Institute
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Open-Angle Glaucoma Therapeutics Market Perspective (2016-2027)
2.2 Open-Angle Glaucoma Therapeutics Growth Trends by Regions
2.2.1 Open-Angle Glaucoma Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Open-Angle Glaucoma Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Open-Angle Glaucoma Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Open-Angle Glaucoma Therapeutics Industry Dynamic
2.3.1 Open-Angle Glaucoma Therapeutics Market Trends
2.3.2 Open-Angle Glaucoma Therapeutics Market Drivers
2.3.3 Open-Angle Glaucoma Therapeutics Market Challenges
2.3.4 Open-Angle Glaucoma Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Open-Angle Glaucoma Therapeutics Players by Revenue
3.1.1 Global Top Open-Angle Glaucoma Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Open-Angle Glaucoma Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Open-Angle Glaucoma Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Open-Angle Glaucoma Therapeutics Revenue
3.4 Global Open-Angle Glaucoma Therapeutics Market Concentration Ratio
3.4.1 Global Open-Angle Glaucoma Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Open-Angle Glaucoma Therapeutics Revenue in 2020
3.5 Open-Angle Glaucoma Therapeutics Key Players Head office and Area Served
3.6 Key Players Open-Angle Glaucoma Therapeutics Product Solution and Service
3.7 Date of Enter into Open-Angle Glaucoma Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Open-Angle Glaucoma Therapeutics Breakdown Data by Type
4.1 Global Open-Angle Glaucoma Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Open-Angle Glaucoma Therapeutics Forecasted Market Size by Type (2022-2027)

5 Open-Angle Glaucoma Therapeutics Breakdown Data by Application
5.1 Global Open-Angle Glaucoma Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Open-Angle Glaucoma Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Open-Angle Glaucoma Therapeutics Market Size (2016-2027)
6.2 North America Open-Angle Glaucoma Therapeutics Market Size by Type
6.2.1 North America Open-Angle Glaucoma Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Open-Angle Glaucoma Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Open-Angle Glaucoma Therapeutics Market Size by Type (2016-2027)
6.3 North America Open-Angle Glaucoma Therapeutics Market Size by Application
6.3.1 North America Open-Angle Glaucoma Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Open-Angle Glaucoma Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Open-Angle Glaucoma Therapeutics Market Size by Application (2016-2027)
6.4 North America Open-Angle Glaucoma Therapeutics Market Size by Country
6.4.1 North America Open-Angle Glaucoma Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Open-Angle Glaucoma Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Open-Angle Glaucoma Therapeutics Market Size (2016-2027)
7.2 Europe Open-Angle Glaucoma Therapeutics Market Size by Type
7.2.1 Europe Open-Angle Glaucoma Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Open-Angle Glaucoma Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Open-Angle Glaucoma Therapeutics Market Size by Type (2016-2027)
7.3 Europe Open-Angle Glaucoma Therapeutics Market Size by Application
7.3.1 Europe Open-Angle Glaucoma Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Open-Angle Glaucoma Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Open-Angle Glaucoma Therapeutics Market Size by Application (2016-2027)
7.4 Europe Open-Angle Glaucoma Therapeutics Market Size by Country
7.4.1 Europe Open-Angle Glaucoma Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Open-Angle Glaucoma Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size by Type
8.2.1 Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size by Application
8.3.1 Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size by Region
8.4.1 Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Open-Angle Glaucoma Therapeutics Market Size (2016-2027)
9.2 Latin America Open-Angle Glaucoma Therapeutics Market Size by Type
9.2.1 Latin America Open-Angle Glaucoma Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Open-Angle Glaucoma Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Open-Angle Glaucoma Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Open-Angle Glaucoma Therapeutics Market Size by Application
9.3.1 Latin America Open-Angle Glaucoma Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Open-Angle Glaucoma Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Open-Angle Glaucoma Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Open-Angle Glaucoma Therapeutics Market Size by Country
9.4.1 Latin America Open-Angle Glaucoma Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Open-Angle Glaucoma Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size by Type
10.2.1 Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size by Application
10.3.1 Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size by Country
10.4.1 Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Aerie Pharmaceuticals Inc.
11.1.1 Aerie Pharmaceuticals Inc. Company Details
11.1.2 Aerie Pharmaceuticals Inc. Business Overview
11.1.3 Aerie Pharmaceuticals Inc. Open-Angle Glaucoma Therapeutics Introduction
11.1.4 Aerie Pharmaceuticals Inc. Revenue in Open-Angle Glaucoma Therapeutics Business (2016-2021)
11.1.5 Aerie Pharmaceuticals Inc. Recent Development
11.2 Allergan Plc
11.2.1 Allergan Plc Company Details
11.2.2 Allergan Plc Business Overview
11.2.3 Allergan Plc Open-Angle Glaucoma Therapeutics Introduction
11.2.4 Allergan Plc Revenue in Open-Angle Glaucoma Therapeutics Business (2016-2021)
11.2.5 Allergan Plc Recent Development
11.3 Bausch Health Companies, Inc.
11.3.1 Bausch Health Companies, Inc. Company Details
11.3.2 Bausch Health Companies, Inc. Business Overview
11.3.3 Bausch Health Companies, Inc. Open-Angle Glaucoma Therapeutics Introduction
11.3.4 Bausch Health Companies, Inc. Revenue in Open-Angle Glaucoma Therapeutics Business (2016-2021)
11.3.5 Bausch Health Companies, Inc. Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Open-Angle Glaucoma Therapeutics Introduction
11.4.4 Novartis AG Revenue in Open-Angle Glaucoma Therapeutics Business (2016-2021)
11.4.5 Novartis AG Recent Development
11.5 Pfizer Inc.
11.5.1 Pfizer Inc. Company Details
11.5.2 Pfizer Inc. Business Overview
11.5.3 Pfizer Inc. Open-Angle Glaucoma Therapeutics Introduction
11.5.4 Pfizer Inc. Revenue in Open-Angle Glaucoma Therapeutics Business (2016-2021)
11.5.5 Pfizer Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Open-Angle Glaucoma Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Prostaglandin Analogs (PGAs)
Table 3. Key Players of Combination of PGAs
Table 4. Key Players of Other
Table 5. Global Open-Angle Glaucoma Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Open-Angle Glaucoma Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Open-Angle Glaucoma Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Open-Angle Glaucoma Therapeutics Market Share by Regions (2016-2021)
Table 9. Global Open-Angle Glaucoma Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Open-Angle Glaucoma Therapeutics Market Share by Regions (2022-2027)
Table 11. Open-Angle Glaucoma Therapeutics Market Trends
Table 12. Open-Angle Glaucoma Therapeutics Market Drivers
Table 13. Open-Angle Glaucoma Therapeutics Market Challenges
Table 14. Open-Angle Glaucoma Therapeutics Market Restraints
Table 15. Global Open-Angle Glaucoma Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Open-Angle Glaucoma Therapeutics Market Share by Players (2016-2021)
Table 17. Global Top Open-Angle Glaucoma Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Open-Angle Glaucoma Therapeutics as of 2020)
Table 18. Ranking of Global Top Open-Angle Glaucoma Therapeutics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Open-Angle Glaucoma Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Open-Angle Glaucoma Therapeutics Product Solution and Service
Table 22. Date of Enter into Open-Angle Glaucoma Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Open-Angle Glaucoma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Open-Angle Glaucoma Therapeutics Revenue Market Share by Type (2016-2021)
Table 26. Global Open-Angle Glaucoma Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Open-Angle Glaucoma Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Open-Angle Glaucoma Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Open-Angle Glaucoma Therapeutics Revenue Market Share by Application (2016-2021)
Table 30. Global Open-Angle Glaucoma Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Open-Angle Glaucoma Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Open-Angle Glaucoma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Open-Angle Glaucoma Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Open-Angle Glaucoma Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Open-Angle Glaucoma Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Open-Angle Glaucoma Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Open-Angle Glaucoma Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Open-Angle Glaucoma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Open-Angle Glaucoma Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Open-Angle Glaucoma Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Open-Angle Glaucoma Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Open-Angle Glaucoma Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Open-Angle Glaucoma Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Open-Angle Glaucoma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Open-Angle Glaucoma Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Open-Angle Glaucoma Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Open-Angle Glaucoma Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Open-Angle Glaucoma Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Open-Angle Glaucoma Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 62. Aerie Pharmaceuticals Inc. Company Details
Table 63. Aerie Pharmaceuticals Inc. Business Overview
Table 64. Aerie Pharmaceuticals Inc. Open-Angle Glaucoma Therapeutics Product
Table 65. Aerie Pharmaceuticals Inc. Revenue in Open-Angle Glaucoma Therapeutics Business (2016-2021) & (US$ Million)
Table 66. Aerie Pharmaceuticals Inc. Recent Development
Table 67. Allergan Plc Company Details
Table 68. Allergan Plc Business Overview
Table 69. Allergan Plc Open-Angle Glaucoma Therapeutics Product
Table 70. Allergan Plc Revenue in Open-Angle Glaucoma Therapeutics Business (2016-2021) & (US$ Million)
Table 71. Allergan Plc Recent Development
Table 72. Bausch Health Companies, Inc. Company Details
Table 73. Bausch Health Companies, Inc. Business Overview
Table 74. Bausch Health Companies, Inc. Open-Angle Glaucoma Therapeutics Product
Table 75. Bausch Health Companies, Inc. Revenue in Open-Angle Glaucoma Therapeutics Business (2016-2021) & (US$ Million)
Table 76. Bausch Health Companies, Inc. Recent Development
Table 77. Novartis AG Company Details
Table 78. Novartis AG Business Overview
Table 79. Novartis AG Open-Angle Glaucoma Therapeutics Product
Table 80. Novartis AG Revenue in Open-Angle Glaucoma Therapeutics Business (2016-2021) & (US$ Million)
Table 81. Novartis AG Recent Development
Table 82. Pfizer Inc. Company Details
Table 83. Pfizer Inc. Business Overview
Table 84. Pfizer Inc. Open-Angle Glaucoma Therapeutics Product
Table 85. Pfizer Inc. Revenue in Open-Angle Glaucoma Therapeutics Business (2016-2021) & (US$ Million)
Table 86. Pfizer Inc. Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Open-Angle Glaucoma Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Prostaglandin Analogs (PGAs) Features
Figure 3. Combination of PGAs Features
Figure 4. Other Features
Figure 5. Global Open-Angle Glaucoma Therapeutics Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Research Institute Case Studies
Figure 9. Other Case Studies
Figure 10. Open-Angle Glaucoma Therapeutics Report Years Considered
Figure 11. Global Open-Angle Glaucoma Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Open-Angle Glaucoma Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Open-Angle Glaucoma Therapeutics Market Share by Regions: 2020 VS 2027
Figure 14. Global Open-Angle Glaucoma Therapeutics Market Share by Regions (2022-2027)
Figure 15. Global Open-Angle Glaucoma Therapeutics Market Share by Players in 2020
Figure 16. Global Top Open-Angle Glaucoma Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Open-Angle Glaucoma Therapeutics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Open-Angle Glaucoma Therapeutics Revenue in 2020
Figure 18. Global Open-Angle Glaucoma Therapeutics Revenue Market Share by Type (2016-2021)
Figure 19. Global Open-Angle Glaucoma Therapeutics Revenue Market Share by Type (2022-2027)
Figure 20. North America Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Open-Angle Glaucoma Therapeutics Market Share by Type (2016-2027)
Figure 22. North America Open-Angle Glaucoma Therapeutics Market Share by Application (2016-2027)
Figure 23. North America Open-Angle Glaucoma Therapeutics Market Share by Country (2016-2027)
Figure 24. United States Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Open-Angle Glaucoma Therapeutics Market Share by Type (2016-2027)
Figure 28. Europe Open-Angle Glaucoma Therapeutics Market Share by Application (2016-2027)
Figure 29. Europe Open-Angle Glaucoma Therapeutics Market Share by Country (2016-2027)
Figure 30. Germany Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Open-Angle Glaucoma Therapeutics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Open-Angle Glaucoma Therapeutics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Open-Angle Glaucoma Therapeutics Market Share by Region (2016-2027)
Figure 40. China Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Open-Angle Glaucoma Therapeutics Market Share by Type (2016-2027)
Figure 48. Latin America Open-Angle Glaucoma Therapeutics Market Share by Application (2016-2027)
Figure 49. Latin America Open-Angle Glaucoma Therapeutics Market Share by Country (2016-2027)
Figure 50. Mexico Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Open-Angle Glaucoma Therapeutics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Open-Angle Glaucoma Therapeutics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Open-Angle Glaucoma Therapeutics Market Share by Country (2016-2027)
Figure 56. Turkey Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Aerie Pharmaceuticals Inc. Revenue Growth Rate in Open-Angle Glaucoma Therapeutics Business (2016-2021)
Figure 60. Allergan Plc Revenue Growth Rate in Open-Angle Glaucoma Therapeutics Business (2016-2021)
Figure 61. Bausch Health Companies, Inc. Revenue Growth Rate in Open-Angle Glaucoma Therapeutics Business (2016-2021)
Figure 62. Novartis AG Revenue Growth Rate in Open-Angle Glaucoma Therapeutics Business (2016-2021)
Figure 63. Pfizer Inc. Revenue Growth Rate in Open-Angle Glaucoma Therapeutics Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

以下、関連資料のご紹介

世界の緑内障診断市場規模・現状・予測（2021年-2027年）

Global Glaucoma Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-5180 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、緑内障診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（開放隅角緑内障、低眼圧緑内障、色素性緑内障、閉鎖隅角緑内障、その他）、用途別市場規模（病院、専門クリニック、その他）、主要地域別市場規模（北米...

世界のオープンアングル緑内障薬産業調査2019-2025

Global Open Angle Glaucoma Drugs Industry Research Report, Growth Trends and Competitive Analysis 2019-2025
QYR9NV16612 2019年11月18日 117Pages
※本調査レポートでは、世界のオープンアングル緑内障薬市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。オープンアングル緑内障薬の種類別には、プロスタグランジン、炭酸脱水酵素阻害剤、コリン作動薬、その他に、用途別には...

世界のオープンアングル緑内障薬産業調査2019-2025

世界のトランスフォーミング増殖因子ベータ 2市場規模・現状・予測（2021年-2027年）

Global Transforming Growth Factor Beta 2 Market Size, Status and Forecast 2021-2027
QFJ1-6050 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、トランスフォーミング増殖因子ベータ 2の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（XOMA-089、トラベダーセン、ISTH-0047、その他）、用途別市場規模（多形性膠芽腫、開放隅角緑内障、肝線...

世界の眼科治療薬/医薬品市場規模・現状・予測（2021年-2027年）

Global Ophthalmic Therapeutics/Drug Market Size, Status and Forecast 2021-2027
QFJ1-4614 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、眼科治療薬/医薬品の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗アレルギー、抗VEGF剤、抗炎症、抗緑内障、その他）、用途別市場規模（ドライアイ、アレルギー、緑内障、感染症、網膜疾患、ブドウ膜炎、...

世界の開胸手術用心臓弁市場規模・現状・予測（2021年-2027年）

Global Open Surgery Heart Valves Market Size, Status and Forecast 2021-2027
QFJ1-4610 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、開胸手術用心臓弁の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（メカニカルバルブ、TAVR）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、...

世界のCOPD治療薬市場規模・現状・予測（2021年-2027年）

Global COPD Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-5676 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、COPD治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（気管支拡張薬、吸入コルチコステロイド、その他）、用途別市場規模（大人用、子供用）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界の未分化甲状腺がん治療薬市場規模・現状・予測（2021年-2027年）

Global Anaplastic Thyroid Cancer Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-3802 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、未分化甲状腺がん治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...

世界のアテローム性動脈硬化症治療薬市場規模・現状・予測（2021年-2027年）

Global Atherosclerosis Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-5602 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、アテローム性動脈硬化症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（小分子、生物製剤）、用途別市場規模（病院、診療所、研究機関、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本...

世界の脾腫治療薬市場規模・現状・予測（2021年-2027年）

Global Splenomegaly Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-6019 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、脾腫治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物療法、予防接種、その他）、用途別市場規模（正常（非脾腫）、中等度脾腫、重度脾腫）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界のオープンアングル緑内障薬産業調査2019-2025 Glaucoma is an eye disease that causes loss of vision and damage to the optic nerve. Open-angle glaucoma, also known as wide-angle glaucoma, is the most common type of glaucoma in the world. Glaucoma is characterized by increased intraocular pressure, which causes damage to the optic nerve.In 2018, …
世界のオープンアングル緑内障薬産業調査2019-2025 Glaucoma is an eye disease that causes loss of vision and damage to the optic nerve. Open-angle glaucoma, also known as wide-angle glaucoma, is the most common type of glaucoma in the world. Glaucoma is characterized by increased intraocular pressure, which causes damage to the optic nerve.In 2018, …
世界の緑内障診断市場規模・現状・予測（2021年-2027年） Glaucoma is one of the largest segments in the global ophthalmic market. Glaucoma can be treated with eye drops, pills, laser surgery, traditional surgery or a combination of these methods. The goal of any treatment is to prevent loss of vision, as vision loss from glaucoma is irreversible. The good…
緑内障治療薬のグローバル市場調査 2019年 The global Glaucoma Medications market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Glaucoma Medications volume and value at global level, regional level and company level. From a global perspective, th…
世界の未熟児網膜症治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Retinopathy Of Prematurity Therapeutics Market The global Retinopathy Of Prematurity Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis…